levodopa has been researched along with Heart Failure in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (51.52) | 18.7374 |
| 1990's | 10 (30.30) | 18.2507 |
| 2000's | 3 (9.09) | 29.6817 |
| 2010's | 2 (6.06) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Adamski, P; Anielska-Michalak, E; Bartuś, S; Brycht, O; Budaj, A; Curzytek, A; Drożdż, J; Dudek, A; Gąsior, M; Gromadziński, L; Gruchała, M; Grzelakowska, K; Grzelakowski, P; Jaguszewski, M; Jankowski, P; Kamiński, L; Kasprzak, M; Kaźmierczak, J; Kleinrok, A; Kostkiewicz, M; Koziński, M; Król, P; Kryś, J; Kubica, A; Kubica, J; Kulawik, T; Legutko, J; Lesiak, M; Leszek, P; Minczew, G; Mindykowski, M; Mitkowski, P; Navarese, EP; Nessler, J; Ostrowska, M; Pawlak, A; Podhajski, P; Prokopczuk, J; Skonieczny, G; Sobkowicz, B; Sowiński, S; Stankala, S; Stolarek, W; Szymański, P; Tomaszuk-Kazberuk, A; Tycińska, A; Wester, A; Wilczewski, P; Zdrojewski, T | 1 |
| Constantinescu, AA; den Uil, CA; Friesema, ECH | 1 |
| Duong-Hua, M; Lang, A; Marras, C; Rochon, P; Sykora, K; Zadikoff, C | 1 |
| Brusselle, G; Camp, Gv; Colao, A; Dieleman, JP; Haag, MD; Haverkamp, W; Herings, R; Luise, Cd; Mazzaglia, G; Mokhles, MM; Ross, D; Schade, R; Sturkenboom, MC; Trifirò, G; van Soest, EM; Verhamme, KM; Zanettini, R | 1 |
| Goldberg, LI; Rajfer, SI | 3 |
| Kaltenbach, M; Sievert, H | 1 |
| Anton, AH; Goldberg, LI; Rajfer, SI; Rossen, JD | 1 |
| Khrustalev, OA | 1 |
| Pouleur, H | 1 |
| Korewicki, J; Leszek, P; Zieliński, T | 1 |
| Brodzki, M; Janas, J; Klimkiewicz, H; Korewicki, J; Leszek, P; Zieliński, T | 1 |
| Dei Cas, L; Metra, M; Nodari, S; Raccagni, D | 1 |
| Beekman, RH; Brown, CE; Chance, WT; Johnson, CE; Mendelsohn, AM | 1 |
| Goldstein, DS; Grossman, E; Peleg, E; Shenkar, A; Thaler, M | 1 |
| Cerqueira-Gomes, M; Damasceno, A; Ferreira, A; Pestana, M; Polónia, J; Soares-da-Silva, P | 1 |
| Bettencourt, P; Cerqueira-Gomes, M; Ferreira, A; Friões, F; Pestana, M; Pimenta, J; Soares-da-Silva, P | 1 |
| Baruch, AL; Davis, C; Hodkinson, HM | 1 |
| Pouleur, H; Raigoso, J; Rousseau, MF | 1 |
| Casagrande, C; La Regina, A; Merlo, L | 1 |
| Danilov, AA; Grigor'iants, RA; Kiseleva, ZM; Mukharliamov, NM | 1 |
| Hasenfuss, G; Holubarsch, C; Kasper, W; Lehmann, M; Meinertz, T | 1 |
| Casagrande, C; Ferrini, R; Merlo, L; Miragoli, G; Semeraro, C | 1 |
| Carey, RA; Jacob, L | 1 |
| Hasenfuss, G; Just, H | 1 |
| Broderick, G; Rajfer, SI | 1 |
| Braunwald, E; Colucci, WS; Wright, RF | 1 |
| Chatterjee, K; Daly, PA; De Marco, T | 1 |
| Busch, W; Hasenfuss, G; Hofmann, T; Holubarsch, C; Just, H; Kasper, W; Krause, T; Lehmann, M; Meinertz, T; Revenaugh, M | 1 |
| Davis, F; Douglas, FL; Nemanich, JW; Osinski, J; Rajfer, SI; Rossen, JD | 1 |
| Amin, DK; Horn, E; Shah, PK | 1 |
7 review(s) available for levodopa and Heart Failure
| Article | Year |
|---|---|
Neurohormonal and hemodynamic effects of ibopamine.
Topics: Clinical Trials as Topic; Deoxyepinephrine; Dopamine Agonists; Heart Failure; Hemodynamics; Humans; Kidney; Levodopa; Norepinephrine; Ventricular Dysfunction, Left | 1995 |
Renal dopaminergic mechanisms in renal parenchymal diseases, hypertension, and heart failure.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Heart Failure; Hemodynamics; Humans; Hypertension, Renal; Kidney Diseases; Kidney Transplantation; Levodopa; Nephrons; Receptors, Dopamine D1; Sodium | 2000 |
Development of dopaminergic drugs for the chronic treatment of congestive heart failure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Deoxyepinephrine; Dopamine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Receptors, Dopamine | 1990 |
Cardiovascular and renal action of dopaminergic prodrugs.
Topics: Animals; Cardiotonic Agents; Cats; Chemical Phenomena; Chemistry; Deoxyepinephrine; Dihydroxyphenylalanine; Dogs; Dopamine; Dopamine Agents; Drug Design; Female; Heart Failure; Hemodynamics; Humans; Kidney; Levodopa; Male; Prodrugs; Rabbits; Rats; Vasodilator Agents | 1989 |
The role of dopaminergic agents and the dopamine receptor in treatment for CHF.
Topics: Benzazepines; Deoxyepinephrine; Dobutamine; Dopamine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Receptors, Dopamine | 1989 |
Clinical relevance of long-term therapy with levodopa and orally active dopamine analogues in patients with chronic congestive heart failure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Administration, Oral; Chronic Disease; Deoxyepinephrine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Vasodilator Agents | 1989 |
New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1.
Topics: Adenylyl Cyclases; Adrenergic alpha-Agonists; Calcium; Cardiotonic Agents; Cyclic AMP; Dobutamine; Dopamine; Drug Tolerance; Glucagon; Heart Failure; Histamine; Humans; Levodopa; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Receptors, Adrenergic; Receptors, Adrenergic, beta; Stimulation, Chemical; Sympathomimetics; Theophylline; Xanthines | 1986 |
2 trial(s) available for levodopa and Heart Failure
| Article | Year |
|---|---|
A randomized crossover trial of levodopa in congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Catecholamines; Catheterization, Swan-Ganz; Cross-Over Studies; Digitalis Glycosides; Diuretics; Dopamine Agents; Drug Therapy, Combination; Electrocardiography, Ambulatory; Heart Failure; Hemodynamics; Humans; Levodopa; Male; Middle Aged; Radiography, Thoracic; Radionuclide Angiography; Ventricular Dysfunction, Left | 1996 |
Renal effects of L-DOPA in heart failure.
Topics: Administration, Oral; Aged; Biological Availability; Catecholamines; Cross-Over Studies; Diuresis; Dopamine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Kidney; Levodopa; Male; Middle Aged; Natriuresis | 1999 |
24 other study(ies) available for levodopa and Heart Failure
| Article | Year |
|---|---|
Impact of COVID-19 pandemic on acute heart failure admissions and mortality: a multicentre study (COV-HF-SIRIO 6 study).
Topics: Acute Disease; Carbidopa; COVID-19; Drug Combinations; Heart Failure; Humans; Levodopa; Pandemics; Retrospective Studies; SARS-CoV-2 | 2022 |
Vasodilation through levodopa for Parkinson's disease may require high left ventricular assist device flow.
Topics: Acute Kidney Injury; Heart Failure; Heart Ventricles; Heart-Assist Devices; Humans; Ischemia; Kidney; Levodopa; Male; Middle Aged; Parkinson Disease; Postoperative Complications; Vasodilation | 2019 |
Pergolide associated cardiac valvulopathy based on Ontario administrative data.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Databases, Factual; Dopamine Agonists; Female; Health Services Administration; Heart Failure; Heart Valve Diseases; Humans; Levodopa; Male; Ontario; Parkinson Disease; Pergolide | 2008 |
The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Case-Control Studies; Cohort Studies; Dopamine Agonists; Female; Heart Failure; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Risk Factors | 2012 |
Sympathomimetic amines: potential clinical applications in ischemic heart disease.
Topics: Animals; Coronary Disease; Deoxyepinephrine; Dobutamine; Dogs; Dopamine; Heart Failure; Humans; Levodopa; Myocardial Contraction; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Dopamine; Sympathomimetics | 1982 |
[New methods in the therapy of chronic heart failure. Is the positive inotropic action of L-dopa currently useful?].
Topics: Heart Failure; Hemodynamics; Humans; Levodopa; Long-Term Care; Myocardial Contraction | 1984 |
Oral levodopa in heart failure.
Topics: Administration, Oral; Aged; Female; Heart Failure; Humans; Levodopa | 1984 |
Beneficial hemodynamic effects of oral levodopa in heart failure. Relation to the generation of dopamine.
Topics: Administration, Oral; Adult; Aged; Biological Availability; Decarboxylation; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Levodopa; Male; Middle Aged; Myocardial Contraction; Time Factors | 1984 |
[Cardiotonic activity of L-DOPA in the treatment of patients with chronic circulatory insufficiency].
Topics: Chronic Disease; Heart Failure; Humans; Levodopa; Rheumatic Heart Disease | 1980 |
[Hemodynamic effects of one administration of l-dopa in patients with left ventricular heart failure (introductory remarks)].
Topics: Adult; Heart Failure; Hemodynamics; Humans; Levodopa; Male; Middle Aged | 1993 |
[Clinical efficacy of oral dopaminergic agents: new findings].
Topics: Administration, Oral; Adrenergic alpha-Agonists; Deoxyepinephrine; Dopamine; Dopamine Agents; Dopamine Agonists; Heart Failure; Hemodynamics; Humans; Kidney; Levodopa; Norepinephrine; Receptors, Dopamine | 1995 |
Hemodynamic and clinical effects of oral levodopa in children with congestive heart failure.
Topics: Adolescent; Cardiac Catheterization; Child; Child, Preschool; Dopamine Agents; Drug Administration Schedule; Echocardiography; Electrocardiography, Ambulatory; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Infant; Levodopa; Male; Time Factors; Treatment Outcome | 1997 |
The renal dopaminergic system, neurohumoral activation, and sodium handling in heart failure.
Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Aldosterone; Atrial Natriuretic Factor; Case-Control Studies; Catecholamines; Creatinine; Dopamine; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Levodopa; Male; Natriuretic Peptide, Brain; Sodium | 2002 |
Causes of high free-thyroxine index values in sick euthyroid elderly patients.
Topics: Atrial Fibrillation; Digitalis Glycosides; Disease; Diuretics; Drug-Related Side Effects and Adverse Reactions; Heart Failure; Humans; Levodopa; Thyroid Gland; Thyroxine | 1976 |
Dopaminergic drugs in the management of chronic heart failure.
Topics: Adult; Deoxyepinephrine; Dopamine Agents; Female; Heart Failure; Hemodynamics; Humans; Levodopa; Male; Middle Aged; Myocardial Contraction; Pilot Projects | 1991 |
[The sympathetic-adrenal system in mitral heart defects in patients of different ages studied by the use of a specific L-DOPA test].
Topics: Adrenal Glands; Adult; Aged; Aging; Dopamine; Epinephrine; Female; Heart Failure; Humans; Levodopa; Male; Middle Aged; Mitral Valve Insufficiency; Mitral Valve Stenosis; Norepinephrine; Sympathetic Nervous System; Vanilmandelic Acid | 1990 |
Catecholamine metabolism in patients with congestive heart failure under acute and chronic oral levodopa therapy.
Topics: Administration, Oral; Catecholamines; Dopamine beta-Hydroxylase; Epinephrine; Heart Failure; Hemodynamics; Humans; Levodopa; Male; Middle Aged; Norepinephrine | 1990 |
The use of levodopa, an oral dopamine precursor, in congestive heart failure.
Topics: Administration, Oral; Dopamine; Heart Failure; Hemodynamics; Humans; Levodopa | 1989 |
Dopamine receptors: applications in clinical cardiology.
Topics: Administration, Oral; Arrhythmias, Cardiac; Benzazepines; Bromocriptine; Deoxyepinephrine; Fenoldopam; Heart Failure; Hemodynamics; Humans; Levodopa; Receptors, Dopamine; Structure-Activity Relationship; Vascular Resistance | 1985 |
The role of adrenergic and dopamine receptors.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiotonic Agents; Deoxyepinephrine; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Levodopa; Receptors, Adrenergic; Receptors, Dopamine | 1985 |
Systemic and coronary hemodynamic and neurohumoral effects of levodopa in chronic congestive heart failure.
Topics: Aged; Aged, 80 and over; Cardiac Output; Dopamine; Female; Heart; Heart Failure; Hemodynamics; Humans; Levodopa; Male; Middle Aged; Myocardium; Neurotransmitter Agents; Norepinephrine; Oxygen Consumption; Vascular Resistance | 1988 |
Evaluation of long-term oral levodopa therapy in chronic congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Chronic Disease; Electrocardiography; Female; Heart Failure; Hemodynamics; Humans; Levodopa; Long-Term Care; Male; Middle Aged; Monitoring, Physiologic | 1987 |
Sustained hemodynamic improvement during long-term therapy with levodopa in heart failure: role of plasma catecholamines.
Topics: Adult; Aged; Cardiac Output; Catecholamines; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Levodopa; Male; Middle Aged; Norepinephrine; Pulmonary Wedge Pressure; Time Factors; Vascular Resistance | 1987 |
Adverse clinical and hemodynamic effects of oral levodopa in chronic congestive heart failure.
Topics: Administration, Oral; Female; Heart Failure; Hemodynamics; Humans; Levodopa; Middle Aged; Monitoring, Physiologic | 1985 |